KEY FEATURES
| Full Name | Erythropoietin |
|---|---|
| Synonym | EP;MVCD2;Epoetin;Hematopoietin;Hemopoietin; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 31.2-2000pg/mL |
| Sensitivity | 11.7pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human EPO in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human EPO. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human EPO and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human EPO, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human EPO. You can calculate the concentration of Human EPO in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human EPO ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 100.85 | 308.02 | 755.75 | 109.76 | 293.96 | 811.83 |
| Standard deviation | 6.34 | 15.37 | 23.05 | 6.86 | 13.26 | 36.78 |
| CV(%) | 6.29 | 4.99 | 3.05 | 6.25 | 4.51 | 4.53 |
RECOVERY
The recovery of Human EPO spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-101 | 95 |
| EDTA plasma (n=8) | 93-108 | 98 |
| Cell culture media (n=8) | 89-99 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human EPO in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with EPO ELISA Kits
| EPOR ELISA Kit | publications with EPO and EPOR |
| JAK2 ELISA Kit | publications with EPO and JAK2 |
| TNF ELISA Kit | publications with EPO and TNF |
| HIF1A ELISA Kit | publications with EPO and HIF1A |
| STAT3 ELISA Kit | publications with EPO and STAT3 |
| VEGFA ELISA Kit | publications with EPO and VEGFA |
| GATA2 ELISA Kit | publications with EPO and GATA2 |
| TFRC ELISA Kit | publications with EPO and TFRC |
Pathways associated with EPO ELISA Kit
| Cellular Response To Hypoxia Pathway | Cellular Response To Hypoxia Pathway |
| Cellular Responses To Stress Pathway | Cellular Responses To Stress Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| EPO Receptor Signaling Pathway | EPO Receptor Signaling Pathway |
| EPO Signaling Pathway | EPO Signaling Pathway |
| HIF-1 Signaling Pathway | HIF-1 Signaling Pathway |
| HIF-1-alpha Transcription Factor Network Pathway | HIF-1-alpha Transcription Factor Network Pathway |
| HIF-2-alpha Transcription Factor Network Pathway | HIF-2-alpha Transcription Factor Network Pathway |
| Hematopoietic Cell Lineage Pathway | Hematopoietic Cell Lineage Pathway |
Diseases associated with EPO ELISA Kit
| Anemia | publications with EPO and Anemia |
| Kidney Diseases | publications with EPO and Kidney Diseases |
| Renal Insufficiency | publications with EPO and Renal Insufficiency |
| Kidney Failure, Chronic | publications with EPO and Kidney Failure, Chronic |
| Vascular Diseases | publications with EPO and Vascular Diseases |
| Nervous System Diseases | publications with EPO and Nervous System Diseases |
| Inflammation | publications with EPO and Inflammation |
| Central Nervous System Diseases | publications with EPO and Central Nervous System Diseases |
| Necrosis | publications with EPO and Necrosis |
| Heart Diseases | publications with EPO and Heart Diseases |
Organs/Tissues associated with EPO ELISA Kit
| Brain | publications with EPO and Brain |
| Eye | publications with EPO and Eye |
| Testis | publications with EPO and Testis |
| Prostate | publications with EPO and Prostate |